國際醫學(000516.SZ):與西北大學簽訂《戰略合作協議》
格隆匯5月25日丨國際醫學(000516.SZ)公佈,公司於2020年5月24日在陝西省西安市與西北大學簽訂了《戰略合作協議》(以下簡稱“協議”),為積極響應“健康中國2030”戰略,深化醫療供給側改革,促進醫療衞生事業發展,經公司與西北大學在平等自願、協商一致的基礎上達成上述協議。
合作具體內容:
1.醫療技術服務
(1)西北大學協助公司旗下醫院完善學科(專科)規劃佈局。雙方確定對口的學科(專科)及團隊,幫助公司旗下醫院按照省級重點專科和優勢學科標準,完成重點專科建設,全面提升醫院綜合實力;
(2)西北大學根據公司需要,組織知名專家赴公司進行學術交流;
(3)西北大學向公司優先推薦優秀畢業生。
2.教學研究改革
(1)西北大學幫助公司建立高層次人才培養體系,為公司培養拔尖技術人才和業務骨幹;公司醫院定期接收西北大學學生的實習和見習;
(2)西北大學遴選公司合格的骨幹教師作為西北大學相關專業的教師和研究生導師,並按相關規定晉升職稱;西北大學協助公司進一步加大專家團隊建設力度,對符合西北大學相關條件的高層次人才,予以積極引進;
(3)雙方共同開展教學研究工作,積極探索醫教協同創新人才培養新模式。
3.科研學術創新
(1)西北大學在國家自然科學基金申報政策、形式要求等方面給予公司指導和幫助;公司每年以西北大學為依託單位,組織申報國家自然科學基金項目;
(2)西北大學指導和幫助公司每年申請其他國家級及省市級科研項目;
(3)西北大學指導和幫助公司每年完成並發表SCI論文。
此次合作有助於增強公司的核心競爭力和可持續發展能力,對公司未來經營發展產生積極影響,本次戰略合作協議的簽訂短期內不會對公司的經營業績帶來重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.